Hepatitis D Market 2025 to 2034
Hepatitis D Market 2025 to 2034
Hepatitis B Market (By Type: Acute, Chronic; By Treatment: Immune Modulator Drugs, Antiviral Drugs, Vaccine, Surgery (Liver Transplant); By Distribution Channel: Hospital & Retail Pharmacies, Online Pharmacies; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2035
Customisation Request
Revenue, 2025
USD 776.10 Mn
Forecast Year, 2035
USD 1,092.71
CAGR, 2025 - 2035
3.48%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global Hepatitis D market, valued at USD 776.10 million in 2025, is projected to grow steadily at a CAGR of 3.48%, reaching approximately USD 1,092.71 million by 2035, driven by rising disease prevalence and advancements in therapeutic interventions.
Hepatitis D Market Size Analysis
Hepatitis D Market Size By Type 2025 to 2034 (USD Million)
| Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Acute | 1.67 | 1.71 | 1.77 | 1.84 | 1.89 | 1.96 | 2.00 | 2.08 | 2.14 | 2.21 |
| Chronic | 3.27 | 3.40 | 3.50 | 3.61 | 3.74 | 3.86 | 4.02 | 4.14 | 4.29 | 4.43 |
Hepatitis D Market Size By Treatment 2025 to 2034 (USD Million)
| Treatment | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Immune Modulator Drugs | 0.50 | 0.52 | 0.53 | 0.55 | 0.57 | 0.59 | 0.60 | 0.62 | 0.65 | 0.67 |
| Antiviral Drugs | 0.99 | 1.02 | 1.06 | 1.09 | 1.13 | 1.16 | 1.20 | 1.25 | 1.28 | 1.33 |
| Vaccine | 1.48 | 1.53 | 1.58 | 1.63 | 1.69 | 1.75 | 1.80 | 1.87 | 1.93 | 1.99 |
| Surgery (Liver Transplant) | 1.97 | 2.03 | 2.11 | 2.18 | 2.25 | 2.33 | 2.41 | 2.48 | 2.56 | 2.65 |
Hepatitis D Market Size By Distribution Channel 2025 to 2034 (USD Million)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital & Retail Pharmacies | 1.66 | 1.71 | 1.77 | 1.82 | 1.87 | 1.96 | 2.01 | 2.08 | 2.14 | 2.22 |
| Online Pharmacies | 3.28 | 3.40 | 3.51 | 3.63 | 3.76 | 3.86 | 4.01 | 4.14 | 4.28 | 4.42 |
Hepatitis D Market Size By Region 2025 to 2034 (USD Million)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.49 | 0.51 | 0.53 | 0.55 | 0.57 | 0.59 | 0.60 | 0.62 | 0.65 | 0.66 |
| LAMEA | 0.99 | 1.02 | 1.06 | 1.09 | 1.13 | 1.16 | 1.20 | 1.25 | 1.28 | 1.33 |
| Europe | 1.48 | 1.53 | 1.58 | 1.63 | 1.69 | 1.75 | 1.81 | 1.86 | 1.92 | 1.99 |
| Asia-Pacific | 1.97 | 2.04 | 2.11 | 2.18 | 2.25 | 2.32 | 2.40 | 2.49 | 2.57 | 2.65 |
Hepatitis D Market Size to Hit USD 1,092.71 Billion by 2035
The global hepatitis d market size surpassed USD 776.10 billion in 2025 and is predicted to reach around USD 1,092.71 billion by 2035 with a registering a CAGR of 3.48%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
